eli lilly acquisition - Stock Newsroom

S TOCK newsroom .COM

S&P 500 7,131 +0.12%

DJIA 49,559 +0.05%

Nasdaq 26,704 +0.25%

DAX 24,501 -0.01%

Gold $4,196 +0.16%

Oil $86.61 +1.03%

BTC $76,054 -0.27%

VIX 20.43 +0.13%

EUR/USD 1.1785 -0.02%

ETH $2,320 -0.68%

S&P 500 7,131 +0.12%

DJIA 49,559 +0.05%

Nasdaq 26,704 +0.25%

DAX 24,501 -0.01%

Gold $4,196 +0.16%

Oil $86.61 +1.03%

BTC $76,054 -0.27%

VIX 20.43 +0.13%

EUR/USD 1.1785 -0.02%

ETH $2,320 -0.68%

eli lilly acquisition

Eli Lilly Acquisition research team working on in-vivo CAR-T cancer and GLP-1 therapy in advanced biotech lab

Pharma & Healthcare·Stocks·USA

Eli Lilly Acquisition Boom: Multi‑Billion Cancer and Obesity Bet

By Maik Kemper • 3h ago

Eli Lilly Acquisition research team working on in-vivo CAR-T cancer and GLP-1 therapy in advanced biotech lab

Pharma & Healthcare·Stocks·USA

Eli Lilly Acquisition Boom: Multi‑Billion Cancer and Obesity Bet

By Maik Kemper • 3h ago

Can the latest Eli Lilly Acquisition in next‑gen cancer therapy really justify its sky‑high valuation beyond the obesity drug boom? Maik Kemper Editor in Chief…